We further observed that the tigecycline and entinostat combination treatment markedly increased phosphorylation of histone γ-H2AX in all three RCC cell lines compared to either agent alone, indicating enhanced DNA damage response [32] (Figure 6B, C). The gene discussed is H2AX; the disease is renal cell carcinoma.